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corticosteroid  therapy  that,  however,  he  has  refused.  A  nor-
malization  of  cholestatic  enzymes  was  observed  while  the
patient  was  still  at  the  hospital  and,  after  8  months  from
diagnosis,  the  patient  remains  asymptomatic  without  anyA  59-year-old  man  presented  with  a  two-week  history  of  epi-
gastric  pain  associated  with  itching  and  jaundice.  Laboratory
investigation:  direct  bilirubin  15xN;  alkaline  phosphatase
3xN;  gamma-GT  6xN;  glucose  2.5xN,  and  normal  levels  of
both  amylase  and  lipase.  CT  scan  of  the  abdomen  showed
diffuse  large  pancreas  with  delay  in  the  uptake  of  contrast
product,  as  well  as  loss  of  normal  pancreatic  lobulation  and  a
heterogeneous  nodular  area  in  the  cephalic  portion.  Abdom-
inal  MRI  revealed  sausage  like  swelling  of  the  pancreas  with
a  surrounding  low  attenuation  rim  and  a  heterogeneousFigure  1  Abdominal  MRI  showing  swelling  of  the  pancreas
with a  surrounding  low  attenuation  rim.
∗ Corresponding author.
E-mail address: paulosalgueiro@gmail.com (P. Salgueiro).
F
n
0872-8178/$ – see front matter © 2013 Sociedade Portuguesa de Gastrentero
http://dx.doi.org/10.1016/j.jpg.2013.04.004odular  area  in  the  cephalic  portion  (Fig.  1). Endoscopic
ltrasound  conﬁrmed  the  heterogeneity  of  the  pancreatic
ephalic  portion  with  a  40  mm  nodule  (Fig.  2).  Aspiration
ytology  guided  by  endoscopic  ultrasound  was  performed,
nd  showed  marked  parenchymal  lymphoplasmacytic  inﬁl-
ration,  storiform  ﬁbrosis  and  obliterative  phlebitis  without
alignant  cells  (Fig.  3A  and  B).  Serologically,  quantiﬁca-
ion  of  IgG  subclasses  allowed  the  discrimination  of  a  raised
gG4  7xN.  The  diagnosis  of  autoimmune  pancreatitis  (AIP)
as  thus  established,  and  the  patient  was  proposed  forigure  2  Endoscopic  ultrasound  showing  a  heterogeneous
odular  area  in  the  pancreatic  cephalic  portion.
logia Published by Elsevier España, S.L. All rights reserved.
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3igure  3  (A  and  B)  Histology  of  the  pancreas  (obtained  by
toriform ﬁbrosis  and  obliterative  phlebitis.
aboratory  abnormality  or  evidence  of  involvement  of  other
rgans  by  the  sclerosing  process  namely  salivary  glands,  bil-
ary  tract,  lungs,  thyroid  or  kidneys.
AIP  is  the  pancreatic  manifestation  of  a  rare,  systemic
isease.1 Its  diagnosis  relies  on  a  combination  of  clinical,
erological,  histological  and  imaging  criteria.2 It  is  impera-
ive  to  differentiate  AIP  from  pancreatic  cancer  owing  to  the
astly  different  prognostic  and  therapeutic  implications.1,2
n  the  case  presented  above  features  such  as  sex,  age,
ymptoms,  diabetes  and  typical  imaging  raised  the  suspi-
ion  of  AIP  that  was  then  conﬁrmed  by  the  presence  of
n  increased  IgG4  and  the  exclusion  of  pancreatic  cancer.
lthough  the  patient  refused  therapy  with  corticosteroids
here  was  a  complete  clinical  and  laboratorial  remission,
hich  did  not  surprise  us  since,  while  therapy  with  cor-
icosteroids  is  recommended  especially  for  patients  with
bstructive  jaundice,3 there  have  been  reports  of  spon-
aneous  resolution  of  pancreatic  masses,  strictures,  and
aundice  in  the  context  of  AIP.4
thical disclosuresrotection  of  human  and  animal  subjects.  The  authors
eclare  that  no  experiments  were  performed  on  humans  or
nimals  for  this  study.
4ration  cytology)  with  marked  lymphoplasmacytic  inﬁltration,
onﬁdentiality  of  data.  The  authors  declare  that  they  have
ollowed  the  protocols  of  their  work  center  on  the  publica-
ion  of  patient  data  and  that  all  the  patients  included  in  the
tudy  received  sufﬁcient  information  and  gave  their  written
nformed  consent  to  participate  in  the  study.
ight  to  privacy  and  informed  consent.  The  authors
eclare  that  no  patient  data  appear  in  this  article.
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